TSHβX1 and D2 THR92ALA in Pregnancy
TSHβX1 Splice Variant Expression and D2 Thr92Ala Polymorphism Analysis in Pregnant Women With Thyroid Diseases
1 other identifier
observational
96
1 country
1
Brief Summary
Thyroid diseases are pathologies that frequently affect pregnant women causing serious complications. This current research aims to find out whether the expression of TSHβX1 splice variant and D2 Thr92Ala polymorphism in the DIO2 gene are associated with thyroid disease in Mexican pregnant women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2018
CompletedFirst Submitted
Initial submission to the registry
July 20, 2018
CompletedFirst Posted
Study publicly available on registry
August 2, 2018
CompletedAugust 2, 2018
July 1, 2018
1.3 years
July 20, 2018
August 1, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
TSHβX1 splice variant expression.
Frequency of positive cases for the TSHβX1 splice variant identified by real-time polymerase change reaction.
Baseline.
Secondary Outcomes (1)
D2 Thr92Ala polymorphism.
Baseline.
Study Arms (2)
Normothyroid pregnant women
Healthy pregnant women with the TSH serum values within the recommended ranged per trimester of pregnancy.
Patients with a thyroid disease
Patients with a thyroid disease named hypothyroidism or hyperthyroidism.
Eligibility Criteria
Pregnant women attended at the "Mónica Pretelini Sáenz" Maternal-Perinatal Hospital are mainly of low socioeconomical status.
You may qualify if:
- Pregnant women attended at the "Mónica Pretelini Sáenz" Maternal-Perinatal Hospital (HMPMPS), Health Institute of the State of Mexico (ISEM), Toluca, Mexico.
You may not qualify if:
- Patients with chronic diseases other than hyper or hypothyroidism.
- Patients that required attention in the obstetric intensive care unit.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Materno-Perinatal Hospital "Mónica Pretelini"
Toluca, 50130, Mexico
Related Publications (2)
Wouters HJ, van Loon HC, van der Klauw MM, Elderson MF, Slagter SN, Kobold AM, Kema IP, Links TP, van Vliet-Ostaptchouk JV, Wolffenbuttel BH. No Effect of the Thr92Ala Polymorphism of Deiodinase-2 on Thyroid Hormone Parameters, Health-Related Quality of Life, and Cognitive Functioning in a Large Population-Based Cohort Study. Thyroid. 2017 Feb;27(2):147-155. doi: 10.1089/thy.2016.0199. Epub 2016 Dec 15.
PMID: 27786042BACKGROUNDLeung AM. Thyroid function in pregnancy. J Trace Elem Med Biol. 2012 Jun;26(2-3):137-40. doi: 10.1016/j.jtemb.2012.03.004. Epub 2012 Jun 2.
PMID: 22658718BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mendieta Zerón
Hospital Materno-Perinatal "Mónica Pretelini Sáenz".
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief of the Research Department
Study Record Dates
First Submitted
July 20, 2018
First Posted
August 2, 2018
Study Start
September 1, 2016
Primary Completion
December 15, 2017
Study Completion
June 30, 2018
Last Updated
August 2, 2018
Record last verified: 2018-07
Data Sharing
- IPD Sharing
- Will not share
The information will be available for academic journals if needed.